Prime Medicine, Inc. PRME
3.89 USD -0.41 (-9.53%)
At closeNov 13, 2026, 5:55 AM EST
3.98 +0.09 +2.31%
Pre-market · Nov 13, 5:55 AM ET
3.73 Day range 4.13
2.67 52-week range 5.91
- YTD
- +12.10%
- 1 year
- +9.58%
PRME revenue history
Revenue is income from the company’s ordinary business activities.
4,632,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 4,632,000 | 1,649,000 | 55.28% |
| FY 2024 | 2024-12-31 | 2,983,000 | 2,983,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | -5,210,000 | -100.00% |
| FY 2020 | 2020-12-31 | 5,210,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:50.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.